Bionano Genomics Inc reports results for the quarter ended in June - Earnings Summary

Bionano Genomics

09/08/2023 22:03

* Bionano Genomics Inc  BNGO.OQ  reported a quarterly
adjusted
loss of $1.24​​ per share for the quarter ended in June. The
mean expectation of four analysts for the quarter was for a loss
of $1.03 per share.
    * Revenue rose 29.9% to $8.66 million from a year ago;
analysts
expected $8.30 million. 
    * Bionano Genomics Inc's reported EPS for the quarter was a
loss
of $1.24​.
    * The mean earnings estimate of analysts had risen by
about 6.1%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates 
    * Bionano Genomics Inc shares had fallen by 34.1% this
quarter and
lost 72.5% so far this year.
    * The company reported a quarterly loss of $38.91 million.
    * Wall Street's median 12-month price target for Bionano
Genomics
Inc is $30.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 5 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 9 at 09:03 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -1.03          -1.24          Missed
 Mar. 31 2023      -1.10          -1.20          Missed
 Dec. 31 2022      -1.10          -1.30          Missed
 Sep. 30 2022      -1.15          -1.10          Beat